Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer

Oral Oncol. 2013 Jan;49(1):79-85. doi: 10.1016/j.oraloncology.2012.07.015. Epub 2012 Aug 20.

Abstract

Objectives: To describe the natural course of distant metastases (DMs) following radiotherapy (RT) or chemoradiotherapy (CRT) in HPV(+) oropharyngeal carcinoma (OPC).

Methods: OPC treated with RT/CRT from 1/1/2000 to 5/31/2010 were reviewed. The natural course of DM were compared between HPV(+) and HPV(-) cohorts.

Results: Median follow-up was 3.9 years. The DM rate were similar (11% vs. 15% at 3-years, p=0.25) between the HPV(+) (n=457) vs. the HPV(-) (n=167) cases. While almost all (24/25) HPV(-) DM occurred within 2-years following RT (1 was at 2.1 years), 7/54 (13%) of HPV(+) DM were detected beyond 3 years (up to 5.3 years). Disseminating to >2 organs occurred in 18 (33%) HPV(+) vs. none in HPV(-). Post-DM survival rates were 11% vs. 4% at 2-years (p=0.02) for the HPV(+) vs. HPV(-) cases respectively. 5/6 HPV(+) with lung oligo-metastasis were still alive with stable disease beyond 2-years after salvage procedures for DM (chemotherapy: 3; surgical resection: 2; radiotherapy: 1).

Conclusions: Although DM rates are similar, the natural course of HPV(+) DM differs from that of HPV(-) patients: it may occur after a longer interval, often with a "disseminating" phenotype, and a small number may have prolonged survival after salvage for DM.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alphapapillomavirus / classification*
  • Carcinoma / radiotherapy
  • Carcinoma / secondary*
  • Carcinoma / therapy
  • Carcinoma / virology
  • Chemoradiotherapy*
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Liver Neoplasms / secondary
  • Liver Neoplasms / virology
  • Lung Neoplasms / secondary
  • Lung Neoplasms / virology
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Staging
  • Oropharyngeal Neoplasms / radiotherapy
  • Oropharyngeal Neoplasms / therapy
  • Oropharyngeal Neoplasms / virology*
  • Papillomavirus Infections / radiotherapy*
  • Papillomavirus Infections / therapy
  • Prospective Studies
  • Radiotherapy Dosage
  • Retrospective Studies
  • Salvage Therapy
  • Skin Neoplasms / secondary
  • Skin Neoplasms / virology
  • Survival Rate
  • Tongue Neoplasms / radiotherapy
  • Tongue Neoplasms / therapy
  • Tongue Neoplasms / virology
  • Tonsillar Neoplasms / radiotherapy
  • Tonsillar Neoplasms / therapy
  • Tonsillar Neoplasms / virology